Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3M Buy
106,730
+6,333
+6% +$169K 0.82% 33
2025
Q4
$2.5M Sell
100,397
-8,940
-8% -$225K 0.7% 37
2025
Q3
$2.79M Buy
109,337
+5,318
+5% +$131K 0.82% 33
2025
Q2
$2.52M Buy
104,019
+6,136
+6% +$143K 0.78% 35
2025
Q1
$2.48M Buy
97,883
+10,923
+13% +$286K 0.83% 30
2024
Q4
$2.31M Sell
86,960
-12,178
-12% -$330K 0.86% 29
2024
Q3
$2.87M Buy
99,138
+8,001
+9% +$233K 1.07% 19
2024
Q2
$2.55M Buy
91,137
+10,584
+13% +$291K 1.01% 20
2024
Q1
$2.24M Buy
80,553
+13,515
+20% +$375K 0.88% 26
2023
Q4
$1.93M Sell
67,038
-1,868
-3% -$56.5K 0.85% 27
2023
Q3
$2.28M Buy
68,906
+5,468
+9% +$193K 1.04% 20
2023
Q2
$2.33M Buy
63,438
+3,034
+5% +$118K 1.07% 18
2023
Q1
$2.46M Buy
60,404
+3,572
+6% +$154K 1.18% 18
2022
Q4
$2.91M Buy
56,832
+6
+0% +$288 1.51% 15
2022
Q3
$2.49M Buy
56,826
+1,789
+3% +$86.9K 1.45% 15
2022
Q2
$2.89M Buy
55,037
+2,401
+5% +$122K 1.62% 14
2022
Q1
$2.73M Sell
52,636
-7,332
-12% -$380K 1.46% 15
2021
Q4
$3.54M Buy
59,968
+2,339
+4% +$116K 1.91% 10
2021
Q3
$2.48M Buy
57,629
+7,956
+16% +$352K 1.42% 15
2021
Q2
$1.95M Buy
49,673
+3,318
+7% +$129K 1.18% 16
2021
Q1
$1.68M Buy
46,355
+4,068
+10% +$144K 1.08% 20
2020
Q4
$1.56M Sell
42,287
-1,688
-4% -$61.9K 0.95% 24
2020
Q3
$1.53M Buy
43,975
+1,388
+3% +$48.7K 1.05% 23
2020
Q2
$1.32M Buy
42,587
+2,268
+6% +$77.1K 1.01% 21
2020
Q1
$1.25M Buy
40,319
+13,395
+50% +$456K 1.25% 19
2019
Q4
$1.01M Buy
+26,924
New +$959K 0.76% 29

Other funds holding PFE

Argent Advisors's PFE Position: Q1 2026 in Review

Argent Advisors increased its Pfizer (PFE) stake by 6.3% in Q1 2026, buying an estimated $169K and bringing the position to 106,730 shares worth $3M. The position accounts for 0.82% of the portfolio, ranked #33.

Argent Advisors first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.54M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Argent Advisors held 106,730 shares of Pfizer worth $3M as of Q1 2026.
  • Argent Advisors bought 6,333 Pfizer shares in Q1 2026, an estimated $169K.
  • Pfizer made up 0.82% of Argent Advisors's portfolio in Q1 2026, its #33 holding.
  • Argent Advisors first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Argent Advisors's Pfizer position peaked at $3.54M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Argent Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.